These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9563884

  • 1. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
    Uckun FM, Narla RK, Jun X, Zeren T, Venkatachalam T, Waddick KG, Rostostev A, Myers DE.
    Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
    [Abstract] [Full Text] [Related]

  • 2. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.
    Uckun FM, Narla RK, Zeren T, Yanishevski Y, Myers DE, Waurzyniak B, Ek O, Schneider E, Messinger Y, Chelstrom LM, Gunther R, Evans W.
    Clin Cancer Res; 1998 May; 4(5):1125-34. PubMed ID: 9607569
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK.
    Cancer Res; 1992 Jul 01; 52(13):3636-41. PubMed ID: 1617636
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.
    Peterson G, Barnes S.
    Cell Growth Differ; 1996 Oct 01; 7(10):1345-51. PubMed ID: 8891338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells.
    Lei W, Mayotte JE, Levitt ML.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):939-45. PubMed ID: 9588219
    [Abstract] [Full Text] [Related]

  • 12. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
    Fitzpatrick SL, LaChance MP, Schultz GS.
    Cancer Res; 1984 Aug 28; 44(8):3442-7. PubMed ID: 6331647
    [Abstract] [Full Text] [Related]

  • 13. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun 28; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 28; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.
    Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG, Hynes NE.
    Cancer Res; 1997 Sep 01; 57(17):3804-11. PubMed ID: 9288791
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.